scispace - formally typeset
J

Jerzy Sadowski

Researcher at Jagiellonian University Medical College

Publications -  286
Citations -  9986

Jerzy Sadowski is an academic researcher from Jagiellonian University Medical College. The author has contributed to research in topics: Aortic valve replacement & Aortic valve. The author has an hindex of 31, co-authored 280 publications receiving 9235 citations. Previous affiliations of Jerzy Sadowski include University of Maryland, Baltimore & University of Oxford.

Papers
More filters
Journal ArticleDOI

Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease

TL;DR: It is indicated that DM2 is potent enough to unfavorably affect plasma fibrin clot characteristics despite abnormal clot phenotype typically observed in CAD.
Journal ArticleDOI

Survival after surgical ablation for atrial fibrillation in mitral valve surgery: Analysis from the Polish National Registry of Cardiac Surgery Procedures (KROK).

TL;DR: Concomitant surgical ablation for AF in patients undergoing mitral valve procedures is safe, feasible, and significantly improves late survival, as well as being associated with nearly 20% improved survival.
Journal ArticleDOI

Altered fibrin clot properties are associated with residual vein obstruction: Effects of lipoprotein(a) and apolipoprotein(a) isoform

TL;DR: Prothrombotic plasma fibrin clot phenotype related to elevated lipoprotein(a) with smaller apolipoprotein( a) isoforms might represent a novel risk factor for RVO.
Journal ArticleDOI

Sutureless aortic valve replacement with the Trilogy Aortic Valve System: Multicenter experience

TL;DR: Sutureless aortic valve replacement is feasible and safe with the Trilogy System, and after an initial learning curve, the modular valve design allows a more rapid and simple implantation compared with conventional stented tissue valves.
Journal ArticleDOI

Fibrin presence within aortic valves in patients with aortic stenosis: association with in vivo thrombin generation and fibrin clot properties.

TL;DR: Large fibrin amounts, mostly co-localised with TF, are present within the valve leaflets of patients with advanced AS, and in vivo thrombin generation andfibrin clot formation are associated with the extent of Fn presence within leaflets, which might contribute to the AS progression.